Neurologic assessment in neuro-oncology (NANO) scale in a prospective phase II trial of anti-PD1 antibody, pembrolizumab with or without bevacizumab in patients with recurrent glioblastoma Meeting Abstract
| Authors: | Nayak, L.; Smith, T.; Gaffey, S. C.; Peters, K. B.; Clarke, J. L.; Jordan, J. T.; De Groot, J. F.; Nghiemphu, P. L.; Kaley, T. J.; Colman, H.; Armstrong, T.; Taphoorn, M. J.; Caruso, V.; Debruyne, M. B.; Bhavsar, C.; Molinaro, A. M.; Severgnini, M.; Wen, P. Y.; Reardon, D. A. |
| Abstract Title: | Neurologic assessment in neuro-oncology (NANO) scale in a prospective phase II trial of anti-PD1 antibody, pembrolizumab with or without bevacizumab in patients with recurrent glioblastoma |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 96s |
| Language: | English |
| ACCESSION: | WOS:000442916001247 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.2037 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 2037 -- Source: Wos |
